HEADER HYDROLASE/HYDROLASE INHIBITOR 20-NOV-18 6N4T TITLE CRYSTAL STRUCTURE OF MATRIPTASE1 IN COMPLEX WITH A PEPTIDOMIMETIC TITLE 2 BENZOTHIAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUPPRESSOR OF TUMORIGENICITY 14 PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MATRIPTASE,MEMBRANE-TYPE SERINE PROTEASE 1,MT-SP1,PROSTAMIN, COMPND 5 SERINE PROTEASE 14,SERINE PROTEASE TADG-15,TUMOR-ASSOCIATED COMPND 6 DIFFERENTIALLY-EXPRESSED GENE 15 PROTEIN; COMPND 7 EC: 3.4.21.109; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ST14, PRSS14, SNC19, TADG15; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A-MTSP (615-855) KEYWDS INHIBITOR COMPLEX, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.CAMPOBASSO REVDAT 2 04-DEC-19 6N4T 1 JRNL REVDAT 1 02-OCT-19 6N4T 0 JRNL AUTH F.BELIVEAU,A.TARKAR,S.P.DION,A.DESILETS,M.G.GHINET, JRNL AUTH 2 P.L.BOUDREAULT,C.ST-GEORGES,E.MARSAULT,D.PAONE,J.COLLINS, JRNL AUTH 3 C.H.MACPHEE,N.CAMPOBASSO,A.GROY,J.COTTOM,M.OUELLETTE, JRNL AUTH 4 A.J.POPE,R.LEDUC JRNL TITL DISCOVERY AND DEVELOPMENT OF TMPRSS6 INHIBITORS MODULATING JRNL TITL 2 HEPCIDIN LEVELS IN HUMAN HEPATOCYTES. JRNL REF CELL CHEM BIOL V. 26 1559 2019 JRNL REFN ESSN 2451-9456 JRNL PMID 31543462 JRNL DOI 10.1016/J.CHEMBIOL.2019.09.004 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.58 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 18515 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 922 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.5848 - 3.7191 1.00 2671 122 0.1509 0.2112 REMARK 3 2 3.7191 - 2.9523 1.00 2554 139 0.1596 0.2101 REMARK 3 3 2.9523 - 2.5792 1.00 2509 147 0.1815 0.2746 REMARK 3 4 2.5792 - 2.3434 1.00 2512 135 0.1744 0.2241 REMARK 3 5 2.3434 - 2.1755 1.00 2488 125 0.1687 0.2226 REMARK 3 6 2.1755 - 2.0472 1.00 2528 119 0.1671 0.2064 REMARK 3 7 2.0472 - 1.9447 0.94 2331 135 0.1821 0.2498 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 1993 REMARK 3 ANGLE : 1.060 2708 REMARK 3 CHIRALITY : 0.060 279 REMARK 3 PLANARITY : 0.005 354 REMARK 3 DIHEDRAL : 15.770 1135 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6N4T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1000238161. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.2 - 8.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18515 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.945 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.69000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, PH 8.2 - 8.7, 18 % - 22 % REMARK 280 PEG800, 200 MM MGCL2, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 33.51450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 70.75950 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 33.51450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 70.75950 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 33.51450 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 70.75950 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 33.51450 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 70.75950 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 481 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 506 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 519 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 530 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 569 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 578 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 579 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 60C CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 203 -162.45 -105.33 REMARK 500 SER A 214 -71.20 -122.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 24 OE1 REMARK 620 2 GLU A 24 OE1 0.0 REMARK 620 3 GLU A 24 OE2 33.8 33.8 REMARK 620 N 1 2 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-(3-PHENYLPROPANOYL)-3-(1,3-THIAZOL-4-YL)-L-ALANYL- REMARK 630 N-[(1S,2S)-1-(1,3-BENZOTHIAZOL-2-YL)-5-CARBAMIMIDAMIDO-1- REMARK 630 HYDROXYPENTAN-2-YL]-L-VALINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 KD7 A 304 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: HCI KCJ VAL KCM REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EOH A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GSH A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue KD7 A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 144 A 305 DBREF 6N4T A 16 244 UNP Q9Y5Y6 ST14_HUMAN 615 855 SEQRES 1 A 241 VAL VAL GLY GLY THR ASP ALA ASP GLU GLY GLU TRP PRO SEQRES 2 A 241 TRP GLN VAL SER LEU HIS ALA LEU GLY GLN GLY HIS ILE SEQRES 3 A 241 CYS GLY ALA SER LEU ILE SER PRO ASN TRP LEU VAL SER SEQRES 4 A 241 ALA ALA HIS CYS TYR ILE ASP ASP ARG GLY PHE ARG TYR SEQRES 5 A 241 SER ASP PRO THR GLN TRP THR ALA PHE LEU GLY LEU HIS SEQRES 6 A 241 ASP GLN SER GLN ARG SER ALA PRO GLY VAL GLN GLU ARG SEQRES 7 A 241 ARG LEU LYS ARG ILE ILE SER HIS PRO PHE PHE ASN ASP SEQRES 8 A 241 PHE THR PHE ASP TYR ASP ILE ALA LEU LEU GLU LEU GLU SEQRES 9 A 241 LYS PRO ALA GLU TYR SER SER MET VAL ARG PRO ILE CYS SEQRES 10 A 241 LEU PRO ASP ALA SER HIS VAL PHE PRO ALA GLY LYS ALA SEQRES 11 A 241 ILE TRP VAL THR GLY TRP GLY HIS THR GLN TYR GLY GLY SEQRES 12 A 241 THR GLY ALA LEU ILE LEU GLN LYS GLY GLU ILE ARG VAL SEQRES 13 A 241 ILE ASN GLN THR THR CYS GLU ASN LEU LEU PRO GLN GLN SEQRES 14 A 241 ILE THR PRO ARG MET MET CYS VAL GLY PHE LEU SER GLY SEQRES 15 A 241 GLY VAL ASP SER CYS GLN GLY ASP SER GLY GLY PRO LEU SEQRES 16 A 241 SER SER VAL GLU ALA ASP GLY ARG ILE PHE GLN ALA GLY SEQRES 17 A 241 VAL VAL SER TRP GLY ASP GLY CYS ALA GLN ARG ASN LYS SEQRES 18 A 241 PRO GLY VAL TYR THR ARG LEU PRO LEU PHE ARG ASP TRP SEQRES 19 A 241 ILE LYS GLU ASN THR GLY VAL HET MG A 301 1 HET EOH A 302 3 HET GSH A 303 20 HET KD7 A 304 47 HET 144 A 305 20 HETNAM MG MAGNESIUM ION HETNAM EOH ETHANOL HETNAM GSH GLUTATHIONE HETNAM KD7 N-(3-PHENYLPROPANOYL)-3-(1,3-THIAZOL-4-YL)-L-ALANYL-N- HETNAM 2 KD7 [(1S,2S)-1-(1,3-BENZOTHIAZOL-2-YL)-5-CARBAMIMIDAMIDO- HETNAM 3 KD7 1-HYDROXYPENTAN-2-YL]-L-VALINAMIDE HETNAM 144 TRIS-HYDROXYMETHYL-METHYL-AMMONIUM FORMUL 2 MG MG 2+ FORMUL 3 EOH C2 H6 O FORMUL 4 GSH C10 H17 N3 O6 S FORMUL 5 KD7 C33 H42 N8 O4 S2 FORMUL 6 144 C4 H12 N O3 1+ FORMUL 7 HOH *180(H2 O) HELIX 1 AA1 ALA A 55 ILE A 60 5 6 HELIX 2 AA2 ASP A 60I THR A 62 5 3 HELIX 3 AA3 ASN A 164 LEU A 172 1 9 HELIX 4 AA4 LEU A 231 LEU A 233 5 3 HELIX 5 AA5 PHE A 234 GLY A 243 1 10 SHEET 1 AA1 8 THR A 20 ASP A 21 0 SHEET 2 AA1 8 GLN A 156 VAL A 162 -1 O LYS A 157 N THR A 20 SHEET 3 AA1 8 MET A 180 GLY A 184 -1 O GLY A 184 N ARG A 161 SHEET 4 AA1 8 GLY A 226 THR A 229 -1 O TYR A 228 N MET A 181 SHEET 5 AA1 8 ILE A 207 TRP A 215 -1 N TRP A 215 O VAL A 227 SHEET 6 AA1 8 PRO A 198 VAL A 202 -1 N SER A 201 O PHE A 208 SHEET 7 AA1 8 ALA A 135 GLY A 140 -1 N TRP A 137 O SER A 200 SHEET 8 AA1 8 GLN A 156 VAL A 162 -1 O ILE A 160 N ILE A 136 SHEET 1 AA2 7 GLN A 30 ALA A 35 0 SHEET 2 AA2 7 GLY A 39 LEU A 46 -1 O CYS A 42 N LEU A 33 SHEET 3 AA2 7 TRP A 51 SER A 54 -1 O VAL A 53 N SER A 45 SHEET 4 AA2 7 ALA A 104 LEU A 108 -1 O ALA A 104 N SER A 54 SHEET 5 AA2 7 GLN A 81 SER A 90 -1 N ILE A 89 O LEU A 105 SHEET 6 AA2 7 TRP A 64 LEU A 68 -1 N ALA A 66 O ARG A 83 SHEET 7 AA2 7 GLN A 30 ALA A 35 -1 N HIS A 34 O THR A 65 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 2 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 3 CYS A 191 CYS A 220 1555 1555 2.04 LINK OE1 GLU A 24 MG MG A 301 1555 1555 2.45 LINK SG CYS A 122 SG2 GSH A 303 1555 1555 2.08 LINK OG SER A 195 C40 KD7 A 304 1555 1555 1.40 LINK OE1 GLU A 24 MG MG A 301 1555 3555 2.71 LINK OE2 GLU A 24 MG MG A 301 1555 3555 2.84 SITE 1 AC1 1 GLU A 24 SITE 1 AC2 3 VAL A 162 ILE A 163 GLN A 165 SITE 1 AC3 8 ARG A 119 PRO A 120 CYS A 122 ARG A 206 SITE 2 AC3 8 ILE A 207 HOH A 408 HOH A 476 HOH A 515 SITE 1 AC4 24 HIS A 57 ARG A 60C GLY A 60D PHE A 99 SITE 2 AC4 24 TYR A 146 GLN A 175 ASP A 189 SER A 190 SITE 3 AC4 24 CYS A 191 GLN A 192 GLY A 193 ASP A 194 SITE 4 AC4 24 SER A 195 SER A 214 TRP A 215 GLY A 216 SITE 5 AC4 24 ASP A 217 GLY A 219 CYS A 220 GLY A 226 SITE 6 AC4 24 HOH A 402 HOH A 428 HOH A 430 HOH A 431 SITE 1 AC5 10 VAL A 17 GLY A 19 GLN A 145 GLN A 156 SITE 2 AC5 10 GLY A 187 ALA A 221 HOH A 412 HOH A 447 SITE 3 AC5 10 HOH A 456 HOH A 473 CRYST1 67.029 141.519 52.109 90.00 90.00 90.00 C 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014919 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007066 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019191 0.00000